Paul Hastings, Nkarta CEO and BIO chair
May 10, 2022 10:43 AM EDT
People

'Front and cen­ter': In­dus­try lead­ers call for re­sponse to Supreme Court abor­tion case draft

Kyle LaHucik

Senior Reporter

Biotech in­dus­try lead­ers want the drug de­vel­op­ment world to stand up and en­sure em­ploy­ees have ac­cess to abor­tions af­ter a draft rul­ing last week re­vealed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times